Generic Drugs: Global collaboration opportunities

  • January 2014
  • -
  • Espicom Business Intelligence
  • -
  • 438 pages

Key facts, statistics and insights on 160 medium-sized generic manufacturers based in 42 countries!

Collaboration is the key to growth

With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems

At one time the generic sector was seen as a valuable way to bring effective products to a wider audience This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector Even markets traditionally based in the provision of branded medicines have made moves to increase generic prescribing

But pressure on health spending is seeing downward pressure on generic prices With lower margins this is creating pain for generics companies

SME Generic companies offer focused opportunities

With established markets compromised, where can the industry go? Expansion in the sector has been seen through more partnering, either through outright acquisition to increase market share or through product and marketing licensing Being bigger and having improved market access is seen as a way of distributing cost and strengthening revenues While major players such as Teva and Sandoz play an international role, there are a number of established and progressive generic manufacturers worthy of consideration

Use this report to…

Identify commercial partners to secure new markets, technologies and revenues
Assess merger and acquisition targets
Understand the developing generic industry in key markets worldwide
Profile the competitive environment in the increasingly important medium-sized company sector
Seek out companies manufacturing/marketing similar product lines
Assess the investment potential of these key companies
Find and assess potential partners and acquisition targets with this report
This new report from Espicom is a key resource for the wide assessment of 160 medium-sized generic companies operating in 42 markets worldwide The report provides an essential and comprehensive evaluation of each company:

Location, establishment and full contact details
Financial information, where available
Products and/or therapy areas
Recent strategic alliances
Delivering the key content you need

• Background
A summary of the company’s foundation and main business interests

• Product range
Details of ANDAs approved or products/therapy areas represented

• Financial
Financial performance or funding data

• Strategic alliances
Details of significant marketing and supply agreements

• Contact information
Postal, telephone, fax and website details


About the Author: Generic Drugs: Global Collaboration Opportunities has been researched and written by Espicom editor Ian Platts In addition to this report, Ian edits the leading newsletter World Generic Markets and has monitored the generics market for over 10 years

Other reports in the series:
World Generic Market Report
(June 2013) VOLUME I: COMPANY PROFILES & VOLUME II: COUNTRY PROFILES
A complete global analysis of the prospects for markets and companies in this dynamic industry sector
Biosimilar Opportunities in an Evolving Market
(August 2013)
The long awaited promise of biosimilars takes another step to fulfilment with the first approval in Europe of high-value second generation products But what products can be expected to follow, who is developing them and what are the hot prospects?
Inhalation & Nasal Spray Generic Drugs
(November 2013)
Comprehensive overview of the challenges and opportunities across the respiratory drugs market, and the FDA’s new product guidance forgeneric inhalers

Table Of Contents

Contents
Companies In This Report1
Company Details In Focus8
Argentina17
Laboratorios Phoenix17
Snapshot 17
Background 17
Products 17
Major Developments 17
Contact Details18
Australia 19
Alchemia19
Snapshot 19
Background19
Products19
Financials20
Major Developments20
Contact Details21
Bangladesh22
Beximco Pharmaceuticals 22
Snapshot 22
Background22
Products22
Financials23
Major Developments23
Contact Details24
Brazil 25
Hypermarcas25
Snapshot 25
Background25
Products25
Financials25
Major Developments26
Contact Details27
LAFEPE28
Snapshot 28
Background28
Products28
Major Developments29
Contact Details29
moksha830
Snapshot 30
Background30
Products30
Major Developments30
Contact Details31
Bulgaria32
Sopharma32
Snapshot 32
Background32
Products32
iii
Generic Drugs
iv

Financials32
Contact Details33
Canada 34
AA Pharma34
Snapshot 34
Background34
Products34
Contact Details35
BioVectra 36
Snapshot 36
Background36
Products36
Major Developments36
Contact Details37
Intellipharmaceutics International 38
Snapshot 38
Background38
Products38
Financials38
Major Developments39
Contact Details40
Chile41
CFR Pharmaceuticals 41
Snapshot 41
Background41
Products42
Financials42
Major Developments42
Contact Details43
China 44
Aoxing Pharmaceutical44
Snapshot 44
Background 44
Products 44
Financials 44
Major Developments45
Contact Details 46
China Pharma Holdings 47
Snapshot 47
Background47
Products47
Financials47
Contact Details 48
Rxmidas/GRMIDAS 49
Snapshot 49
Background49
Products49
Financials49
Major Developments49
Contact Details50
Zhejiang Huahai Pharmaceuticals 51
Snapshot 51
Background51
v

Products51
Contact Details51
Cyprus 52
Medochemie 52
Snapshot 52
Background52
Products52
Contact Details52
Egypt 53
EIPICo 53
Snapshot 53
Background53
Products53
Contact Details53
France 54
BioAlliance Pharma54
Snapshot 54
Background54
Financials55
Major Developments55
Contact Details57
Germa ny 58
Alfred E Tiefenbacher (AET) 58
Snapshot 58
Background58
Products58
Major developments58
Contact Details59
Fresenius Kabi60
Snapshot 60
Background60
Products60
Financials 62
Major Developments62
Contact Details 64
Greece 65
Genepharm 65
Snapshot 65
Background65
Products65
Contact Details66
Pharmathen 67
Snapshot 67
Background67
Products67
Financials67
Contact Details67
India 68
Alembic 68
Snapshot 68
Background68
vi

Products68
Financials69
Major Developments70
Contact Details71
Alkem 72
Snapshot 72
Background72
Products72
Major Developments73
Contact Details73
Bafna Pharmaceuticals 74
Snapshot 74
Background74
Products74
Financials75
Major Developments75
Contact Details76
Bharat Serums and Vaccines 77
Snapshot 77
Background77
Products77
Contact Details78
Biocon 79
Snapshot 79
Background79
Products79
Financials80
Major Developments81
Contact Details83
Claris Lifesciences84
Snapshot 84
Background 84
Products 84
Financials85
Major Developments86
Contact Details87
Emcure88
Snapshot 88
Background88
Products88
Major Developments89
Contact Details89
Gland Pharma90
Snapshot 90
Background90
Products90
Major Developments90
Contact Details91
Glenmark Pharmaceuticals 92
Snapshot 92
Background92
Products92
Financials94
Major Developments96
Contact Details97
vii

Granules India 98
Snapshot 98
Background98
Products98
Financials99
Major Developments99
Contact Details99
Hetero Drugs100
Snapshot 100
Background 100
Products 100
Major Developments 101
Contact Details 103
Indoco Remedies 104
Snapshot104
Background 104
Products104
Financials 105
Major Developments 105
Contact Details 106
Intas Pharmaceuticals 107
Snapshot107
Background 107
Products107
Financials 108
Major Developments 108
Contact Details 109
Ipca Laboratories110
Snapshot110
Background 110
Products110
Financials 110
Contact Details 112
JB Chemicals and Pharmaceuticals 113
Snapshot113
Background 113
Products113
Financials 113
Major Developments 114
Contact Details 115
Jubilant Life Sciences 116
Snapshot116
Background 116
Products116
Financials 117
Major Developments 118
Contact Details 119
Macleods Pharmaceuticals 120
Snapshot120
Background 120
Products120
Contact Details 121
Marksans Pharma 122
Snapshot122
Background 122
viii

Products122
Financials 122
Contact Details 123
Micro Labs 124
Snapshot124
Background 124
Products124
Major Developments 124
Contact Details 125
Natco Pharma 126
Snapshot126
Background 126
Products126
Financials 127
Major Developments 128
Contact Details 130
Orchid Chemicals and Pharmaceuticals 131
Snapshot131
Background 131
Products131
Financials 133
Major Developments 133
Contact Details 134
RPG Life Sciences 135
Snapshot135
Background 135
Products135
Financials 135
Major Developments 136
Contact Details 136
Shasun Pharmaceuticals 137
Snapshot137
Background 137
Products137
Financials 137
Major Developments 138
Contact Details 139
Strides Arcolab140
Snapshot140
Background 140
Products140
Financials 142
Major Developments 143
Contact Details 145
Torrent Pharmaceuticals 146
Snapshot146
Background 146
Products146
Financials 147
Major Developments 148
Contact Details 149
Unichem Laboratories 150
Snapshot150
Background 150
Products150
ix

Financials 151
Major Developments 152
Contact Details 152
Venus Remedies 153
Snapshot153
Background 153
Products153
Financials 153
Major Developments 154
Contact Details 154
Ireland155
Consilient Health 155
Snapshot155
Background 155
Products155
Contact Details 156
Reliance GeneMedix 157
Snapshot157
Background 157
Products157
Financials 157
Major Developments 158
Contact Details 159
Italy 160
ACS Dobfar160
Snapshot160
Background 160
Products160
Contact Details 161
Japa n 162
Nichi-Iko Pharmaceutical 162
Snapshot162
Background 162
Products162
Financials 162
Major Developments 163
Contact Details 163
Nippon Chemiphar 164
Snapshot164
Background 164
Products164
Financials 164
Contact Details 165
Towa Pharmaceutical166
Snapshot166
Background 166
Products166
Financials 166
Contact Details 167
Jorda n 168
Hikma Pharmaceuticals168
Snapshot168
x

Background 168
Products168
Financials 171
Major Developments 171
Contact Details 175
Kenya176
Regal Pharmaceuticals 176
Snapshot176
Background 176
Products176
Contact Details 176
La tvia 177
Grindeks 177
Snapshot177
Background 177
Products177
Financials 177
Major Developments 178
Contact Details 179
Lithuania 180
Sanitas180
Snapshot180
Background 180
Products180
Financials 181
Major Developments 182
Contact Details 182
Malaysia 183
CCM Pharmaceuticals 183
Snapshot183
Background 183
Products183
Financials 184
Major Developments 184
Contact Details 185
Malaysia 186
Inno Biologics 186
Snapshot186
Background 186
Products186
Contact Details 187
Pharmaniaga Berhad188
Snapshot188
Background 188
Products188
Financials 188
Major Developments 189
Contact Details 189
Mexic o 190
Genomma Lab190
Snapshot190
xi

Background 190
Products190
Financials 190
Contact Details 191
Netherlands 192
Genmed Holding 192
Snapshot192
Background 192
Products192
Financials 192
Major Developments 193
Contact Details 193
Synthon194
Snapshot194
Background 194
Products194
Major Developments 195
Contact Details 196
New Zealand 197
Douglas Pharmaceuticals 197
Snapshot197
Background 197
Products197
Financials 197
Contact Details 198
Norway 199
Navamedic199
Snapshot199
Background 199
Products199
Financials 200
Major Developments 200
Contact Details 201
Oma n 202
Oman Pharmaceutical Products202
Snapshot 202
Background 202
Products 202
Major Developments 202
Contact Details 203
Poland 204
Polpharma 204
Snapshot 204
Background 204
Products 204
Major Developments 204
Contact Details 206
Portugal 207
Hovione207
Snapshot 207
Background 207
xii

Products 207
Financials 208
Major Developments 208
Litigation 208
Contact Details 208
Roma nia 209
Antibiotice 209
Snapshot 209
Background 209
Products 209
Financials 209
Major Developments 210
Contact Details 210
Russia 211
R-Pharm211
Snapshot211
Background 211
Products211
Financials 211
Major Developments 212
Contact Details 212
South Africa 213
Adcock Ingram 213
Snapshot213
Background 213
Products214
Financials 216
Major Developments 218
Contact Details 221
Cipla Medpro222
Snapshot 222
Background 222
Products 222
Financials 223
Major Developments 224
Contact Details 225
Litha Healthcare226
Snapshot 226
Background 226
Products 226
Financials 226
Major Developments 227
Contact Details 228
Pharma Dynamics229
Snapshot 229
Background 229
Products 229
Contact Details 229
Sonke Pharmaceuticals230
Snapshot 230
Background 230
Products 230
Major Developments 230
xiii

Contact Details 231
South Korea 232
Hanmi Pharmaceutical232
Snapshot232
Background 232
Products232
Financials 233
Major Developments 234
Contact Details 236
Spai n 237
Laboratorios Cinfa237
Snapshot237
Background 237
Products237
Financials 237
Major Developments 238
Contact Details 238
Sweden 239
Bluefish Pharmaceuticals239
Snapshot 239
Background 239
Products 239
Financials 239
Major Developments 240
Contact Details 241
Switzerland 242
Acino242
Snapshot 242
Background 242
Products 242
Financials 243
Major Developments 243
Contact Details 245
Legacy Pharmaceuticals International 246
Snapshot 246
Background 246
Products 246
Contact Details 246
Tai wan 247
ScinoPharm Taiwan 247
Snapshot247
Background 247
Products 248
Financials 248
Major Developments 249
Contact Details 250
Thailand 251
Government Pharmaceutical Organisation251
Snapshot251
Background 251
Products251
xiv

Contact Details 252
Turkey 253
Abdi Ibrahim253
Snapshot253
Background 253
Products253
Major Developments 254
Contact Details 254
EastPharma255
Snapshot255
Background 255
Products255
Financials 255
Contact Details 256
Mustafa Nevzat Pharmaceuticals 257
Snapshot257
Background 257
Products257
Major Developments 258
Contact Details 258
UK 259
Amdipharm Mercury (AMCo)259
Snapshot 259
Background 259
Products 260
Financials 260
Major Developments 261
Contact Details 261
Kent Pharmaceuticals262
Snapshot 262
Background 262
Products 262
Major Developments 262
Contact Details 263
Syntropharma264
Snapshot 264
Background 264
Products 264
Major Developments 264
Contact Details 265
USA 266
Acella Pharmaceuticals266
Snapshot 266
Background 266
Products 266
Contact Details 266
Aceto267
Snapshot267
Background 267
Products267
Financials 267
Contact Details 268
Akorn269
xv

Snapshot 269
Background 269
Products270
Financials 271
Major Developments 272
Contact Details 273
Alvogen 274
Snapshot274
Background 274
Products274
Major Developments 275
Contact Details 277
Amerigen Pharmaceuticals278
Snapshot278
Background 278
Products278
Major Developments 278
Contact Details 280
Amneal Pharmaceuticals281
Snapshot281
Background 281
Products281
Major Developments 283
Contact Details 284
Amphastar Pharmaceuticals 285
Snapshot 285
Background 285
Products 285
Major Developments 286
Contact Details 287
Antares Pharma288
Snapshot 288
Background 288
Products 288
Financials 289
Major Developments 289
Contact Details 290
Apicore291
Snapshot291
Background 291
Products291
Contact Details 292
AustarPharma293
Snapshot 293
Background 293
Products 293
Major Developments 293
Contact Details 294
Avanthi295
Snapshot 295
Background 295
Products 295
Contact Details 295
Bedford Laboratories296
Snapshot 296
xvi

Background 296
Products 296
Major Developments 298
Contact Details 299
Belcher Pharmaceuticals300
Snapshot 300
Background 300
Products 300
Contact Details 300
Biokey 301
Snapshot301
Background 301
Products301
Contact Details 301
Boca Pharmacal 302
Snapshot302
Background 302
Products302
Major Developments 302
Contact Details 303
Breckenridge Pharmaceutical 304
Snapshot 304
Background 304
Products 304
Major Developments 304
Contact Details 306
Cambrex 307
Snapshot307
Background 307
Products307
Financials 307
Major Developments 308
Contact Details 309
Carlsbad Technology 310
Snapshot310
Background 310
Products310
Contact Details 310
Cephazone Pharma 311
Snapshot311
Background 311
Products311
Contact Details 311
CorePharma 312
Snapshot312
Background 312
Products312
Major Developments 313
Contact Details 313
Cypress Pharmaceutical 314
Snapshot314
Background 314
Products314
Major Developments 314
Contact Details 315
xvii

Elite Pharmaceuticals 316
Snapshot316
Background 316
Products316
Financials 316
Major Developments 317
Contact Details 318
Epic Pharma 319
Snapshot319
Background 319
Products319
Major Developments 319
Contact Details 320
EPIRUS Biopharmaceuticals 321
Snapshot321
Background 321
Products321
Major Developments 321
Contact Details 322
Exela 323
Snapshot323
Background 323
Major Developments 323
Contact Details 324
Ferndale Pharma Group 325
Snapshot325
Background 325
Products325
Major Developments 326
Contact Details 326
Fougera327
Snapshot327
Background 327
Products327
Major developments 328
Contact Details 329
GandW Laboratories330
Snapshot330
Background 330
Products330
Contact Details 331
GeneraMedix Pharmaceuticals332
Snapshot332
Background 332
Products332
Major Developments 333
Contact Details 333
Greenstone334
Snapshot334
Background 334
Products334
Major Developments 334
Contact Details 335
Handa Pharmaceuticals336
Snapshot336
xviii

Background 336
Products336
Major Developments 336
Contact Details 337
Hanford Pharmaceuticals338
Snapshot338
Background 338
Products338
Major Developments 338
Contact Details 339
Harris Pharmaceutical340
Snapshot 340
Background 340
Products 340
Contact Details 340
Hi-Tech Pharmacal 341
Snapshot341
Background 341
Products341
Financials 342
Major Developments 343
Contact Details 344
IGI Laboratories 345
Snapshot 345
Background 345
Products 345
Financials 345
Major Developments 346
Contact Details 346
Indicus Pharma347
Snapshot347
Background 347
Products347
Contact Details 348
InvaGen Pharmaceuticals349
Snapshot 349
Background 349
Products 349
Contact Details 350
Kadmon Pharmaceuticals 351
Snapshot351
Background 351
Products351
Major Developments 351
Contact Details 352
Kremers Urban Pharmaceuticals353
Snapshot353
Background 353
Products353
Major Developments 354
Contact Details 354
KVK-Tech 355
Snapshot355
Background 355
Products355
xix

Major Developments 355
Contact Details 356
Lehigh Valley Technologies357
Snapshot357
Background 357
Products357
Major Developments 357
Contact Details 358
Luitpold Pharmaceuticals359
Snapshot359
Background 359
Products359
Major Developments 361
Contact Details 362
Lyne Laboratories363
Snapshot 363
Background 363
Products 363
Contact Details 363
Mallinckrodt364
Snapshot 364
Background 364
Products 364
Major Developments 365
Contact Details 366
Mikart367
Snapshot367
Background 367
Products367
Contact Details 368
Nexgen Pharma369
Snapshot 369
Background 369
Products 369
Contact Details 369
Nexus Pharmaceuticals370
Snapshot370
Background 370
Products370
Major Developments 370
Contact Details 371
Nostrum Pharmaceuticals372
Snapshot372
Background 372
Products372
Major Developments 372
Contact Details 373
Novel Laboratories 374
Snapshot374
Background 374
Products374
Major Developments 375
Contact Details 375
Orit Laboratories 376
Snapshot376
xx

Background 376
Products376
Contact Details 376
Osmotica Pharmaceutical377
Snapshot377
Background 377
Products377
Major Developments 378
Contact Details 378
Patheon379
Snapshot379
Background 379
Products379
Financials 380
Major Developments 381
Contact Details 382
Pharmaceutical Associates 383
Snapshot 383
Background 383
Products 383
Contact Details 383
Prasco Laboratories384
Snapshot 384
Background 384
Products 384
Major Developments 384
Contact Details 386
Precision Dose387
Snapshot 387
Background 387
Products 387
Major Developments 387
Contact Details 388
Qualitest Pharmaceuticals 389
Snapshot 389
Background 389
Products 389
Financials 391
Major Developments 392
Contact Details 392
Roxane Laboratories 393
Snapshot393
Background 393
Products393
Major Developments 395
Contact Details 396
Sigmapharm Laboratories 397
Snapshot397
Background 397
Products397
Contact Details 397
Silarx Pharmaceuticals 398
Snapshot 398
Background 398
Products 398
xxi

Contact Details 398
SOHM399
Snapshot 399
Background 399
Products 399
Financials 399
Major Developments 400
Contact Details 401
Spear Pharmaceuticals402
Snapshot 402
Background 402
Products 402
Major Developments 402
Contact Details 402
Stason Pharmaceuticals403
Snapshot 403
Background 403
Products 403
Major Developments 403
Contact Details 404
Tolmar 405
Snapshot 405
Background 405
Products 405
Major Developments 405
Contact Details 406
Tris Pharma407
Snapshot 407
Background 407
Products 407
Major Developments 408
Contact Details 408
Upsher-Smith Laboratories409
Snapshot 409
Background 409
Products 409
Major Developments 410
Contact Details 410
VersaPharm411
Snapshot411
Background 411
Products411
Contact Details 412
VistaPharm 413
Snapshot413
Background 413
Products413
Contact Details 413
X-GEN Pharmaceutical 414
Snapshot414
Background 414
Products414
Major Developments 414
Contact Details 415
xxii

Vietnam416
Nanogen Biopharmaceutical 416
Snapshot416
Background 416
Products416
Contact Details 416

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Analyzing the Global Generics Industry 2014

Analyzing the Global Generics Industry 2014

  • $ 1 750
  • Industry report
  • August 2014
  • by Aruvian's R'search

In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global ...

Detailed I/E report of Fipronil export analysis

Detailed I/E report of Fipronil export analysis

  • $ 5 400
  • Industry report
  • July 2014
  • by CCM International Limited

Fipronil export analysis will help clients understandthe export situation of technical and formulations with exclusive research methods and offer not only the products'export volume, price, time, source ...

Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists -Pipeline Insights, 2014

Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Calcitonin Gene-Related Peptide Receptor (CRLR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

Global Markets For Generic Drugs

January 2014 $ 6 650

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.